320 related articles for article (PubMed ID: 1347338)
1. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
3. Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?
Sterne JA; Fine PE; Pönnighaus JM; Sibanda F; Munthali M; Glynn JR
Tuber Lung Dis; 1996 Apr; 77(2):117-23. PubMed ID: 8762845
[TBL] [Abstract][Full Text] [Related]
4. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of BCG against leprosy in Northern Malawi.
Fine PE; Ponnighaus JM; Maine N; Clarkson JA; Bliss L
Lancet; 1986 Aug; 2(8505):499-502. PubMed ID: 2875247
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
[TBL] [Abstract][Full Text] [Related]
8. Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi.
Fine PE; Ponnighaus JM
Trans R Soc Trop Med Hyg; 1988; 82(6):810-7. PubMed ID: 3076995
[TBL] [Abstract][Full Text] [Related]
9. The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase.
Pönnighaus JM; Fine PE; Bliss L; Gruer PJ; Kapira-Mwamondwe B; Msosa E; Rees RJ; Clayton D; Pike MC; Sterne JA
Lepr Rev; 1993 Dec; 64(4):338-56. PubMed ID: 8127221
[TBL] [Abstract][Full Text] [Related]
10. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
12. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
14. Differential protective effect of bacillus Calmette-Guerin vaccine against multibacillary and paucibacillary leprosy in Nagpur, India.
Kulkarni HR; Zodpey SP
Public Health; 1999 Nov; 113(6):311-3. PubMed ID: 10637526
[TBL] [Abstract][Full Text] [Related]
15. The distribution and implications of BCG scars in northern Malawi.
Fine PE; Ponnighaus JM; Maine N
Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccination protects against leprosy in Venezuela: a case-control study.
Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
[TBL] [Abstract][Full Text] [Related]
17. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
Zodpey SP
Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
[TBL] [Abstract][Full Text] [Related]
18. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based case-control study in Nagpur, India.
Zodpey SP; Bansod BS; Shrikhande SN; Maldhure BR; Kulkarni SW
Lepr Rev; 1999 Sep; 70(3):287-94. PubMed ID: 10603718
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis prevention: where do we go from here?
Warndorff DK
Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
